ARTICLE | Company News
Hypnion, Eli Lilly deal
March 12, 2007 7:00 AM UTC
LLY will acquire Hypnion for an undisclosed amount of cash. Hypnion's oral HY10275 is in Phase II testing to treat insomnia by improving both sleep induction and maintenance. In January, Phase II data...